Pan-Cancer Analysis Identifies Liver Metastases as Negative Predictive Factor for Immune Checkpoint Inhibitors Treatment Outcome

Pan-Cancer Analysis Identifies Liver Metastases as Negative Predictive Factor for Immune Checkpoint Inhibitors Treatment Outcome

This study aimed to investigate the predictive value of liver metastases (LM) in patients with various advanced cancers received immune-checkpoint inhibitors (ICIs). First, clinical and survival data from a published cohort of 1,661 patients who received ICIs therapy were downloaded and analyzed. Se...

Full description

Bibliographic Details
Main Authors:	Xiao-Juan Chen, Aiqun Ren, Liang Zheng, En-Dian Zheng, Tao Jiang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-06-01
Series:	Frontiers in Immunology
Subjects:	pan-cancer liver metastases immune checkpoint inhibitor prognosis treatment outcome
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.651086/full

Similar Items

Stereotactic Radiosurgery and Immune Checkpoint Inhibitors in the Management of Brain Metastases
by: Eric J. Lehrer, et al.
Published: (2018-10-01)

Pan‐cancer analysis identifies TERT alterations as predictive biomarkers for immune checkpoint inhibitors treatment
by: Tao Jiang, et al.
Published: (2020-06-01)

Predictive Value of KDM5C Alterations for Immune Checkpoint Inhibitors Treatment Outcomes in Patients With Cancer
by: Xiao-Juan Chen, et al.
Published: (2021-04-01)

EPHA7 mutation as a predictive biomarker for immune checkpoint inhibitors in multiple cancers
by: Zhen Zhang, et al.
Published: (2021-02-01)

Outcome of Patients with NSCLC and Brain Metastases Treated with Immune Checkpoint Inhibitors in a ‘Real-Life’ Setting
by: Marcus Skribek, et al.
Published: (2020-12-01)

The Current Status of Immune Checkpoint Inhibitors in Neuro-Oncology: A Systematic Review
by: Cyrillo G. Brahm, et al.
Published: (2020-03-01)

Combination of Immune Checkpoint Inhibitors and Anti-Angiogenic Agents in Brain Metastases From Non-Small Cell Lung Cancer
by: Likui Fang, et al.
Published: (2021-05-01)

Immune Checkpoint Inhibitors: The Emerging Cornerstone in Cholangiocarcinoma Therapy?
by: María Gutiérrez-Larrañaga, et al.
Published: (2021-09-01)

Research Progress of Immunotherapy for Brain Metastases in Patients  with Drive Gene Negative NSCLC
by: Shuang ZHANG, et al.
Published: (2018-08-01)

The Effect of Asymptomatic and/or Treated Brain Metastases on Efficacy of Immune Checkpoint Inhibitors in Metastatic Non–Small Cell Lung Cancer: A Meta-Analysis
by: Sihan Li, et al.
Published: (2021-06-01)

Immune Checkpoint Inhibitors and Survival Outcomes in Brain Metastasis: A Time Series-Based Meta-Analysis
by: Xingjiang Hu, et al.
Published: (2020-10-01)

Increased occurrence of status epilepticus in patients with brain metastases and checkpoint inhibition
by: Hans Urban, et al.
Published: (2020-01-01)

Immune Checkpoint Blockade – How Does It Work in Brain Metastases?
by: Mihaela Lorger, et al.
Published: (2019-11-01)

Complete intracranial response to talimogene laherparepvec (T-Vec), pembrolizumab and whole brain radiotherapy in a patient with melanoma brain metastases refractory to dual checkpoint-inhibition
by: Zoë Blake, et al.
Published: (2018-04-01)

Serum Levels of Soluble Urokinase Plasminogen Activator Receptor Predict Tumor Response and Outcome to Immune Checkpoint Inhibitor Therapy
by: Sven H. Loosen, et al.
Published: (2021-04-01)

A Pan-Cancer Approach to Predict Responsiveness to Immune Checkpoint Inhibitors by Machine Learning
by: Maurizio Polano, et al.
Published: (2019-10-01)

Peptide and peptide-inspired checkpoint inhibitors: Protein fragments to cancer immunotherapy
by: Pottayil G. Sasikumar, et al.
Published: (2020-12-01)

Clinical diagnosis and treatment of immune checkpoint inhibitor‐associated pneumonitis
by: Hanping Wang, et al.
Published: (2020-01-01)

Survival prediction and response to immune checkpoint inhibitors: A prognostic immune signature for hepatocellular carcinoma
by: Ying Xu, et al.
Published: (2021-01-01)

PD-1/PD-L1 Inhibitor Combined with Chemotherapy Can Improve the Survival of Non-Small Cell Lung Cancer Patients with Brain Metastases
by: Sun C, et al.
Published: (2020-12-01)

Prognosis of Lung Adenocarcinoma Patients With NTRK3 Mutations to Immune Checkpoint Inhibitors
by: Yuchun Niu, et al.
Published: (2020-08-01)

Progressive Sarcopenia Correlates with Poor Response and Outcome to Immune Checkpoint Inhibitor Therapy
by: Sven H. H. Loosen, et al.
Published: (2021-03-01)

Clinical Diagnosis and Treatment Recommendations for the Pneumonitis Associated with Immune Checkpoint Inhibitor
by: Hanping WANG, et al.
Published: (2019-10-01)

Radiographic features and prognosis of early- and late-onset non-small cell lung cancer immune checkpoint inhibitor-related pneumonitis
by: Aiben Huang, et al.
Published: (2021-05-01)

Immune Checkpoint Inhibitors in Prostate Cancer
by: Shobi Venkatachalam, et al.
Published: (2021-05-01)

Progress of Steroids Effect on Efficacy of Immune Checkpoint Inhibitors
by: Guoqiang PAN, et al.
Published: (2019-12-01)

Calcineurin inhibitors in steroid and anti‐TNF‐alpha refractory immune checkpoint inhibitor colitis
by: Eva Zhang, et al.
Published: (2021-05-01)

Checkpoint inhibitor-induced sarcoid choroidal granulomas
by: Cindy Ung, et al.
Published: (2020-06-01)

Checkpoint Inhibitor-Induced Gastroduodenitis: An Unusual Manifestation
by: Rui Mendo, et al.
Published: (2020-08-01)

Immune checkpoint inhibitor myocarditis: a systematic case study
by: E. A. Kushnareva, et al.
Published: (2020-12-01)

The Prognostic Value of ctDNA and bTMB on Immune Checkpoint Inhibitors in Human Cancer
by: Jiayan Wei, et al.
Published: (2021-10-01)

Identification of a prognostic immune signature for cervical cancer to predict survival and response to immune checkpoint inhibitors
by: Si Yang, et al.
Published: (2019-12-01)

Catenin Alpha-2 Mutation Changes the Immune Microenvironment in Lung Adenocarcinoma Patients Receiving Immune Checkpoint Inhibitors
by: Yang Wen, et al.
Published: (2021-06-01)

Case Report: Pulmonary Metastases From Epithelioid Sarcoma in Extremity Favourably Responding to Immunotherapy With Camrelizumab
by: Tao-Jun Gong, et al.
Published: (2021-10-01)

Ipilimumab (Immune Checkpoint Inhibitors) Hypophysitis
by: Margot Stagnetto, et al.
Published: (2020-11-01)

Antibiotic therapy and outcome from immune-checkpoint inhibitors
by: David J. Pinato, et al.
Published: (2019-11-01)

Research Progress of Immune Checkpoint Inhibitor-associated Myocarditis
by: Yunwei LIU, et al.
Published: (2021-09-01)

Control of renal cell carcinoma brain metastases with cabozantinib following progression on immune checkpoint inhibitor therapy
by: Cierra Hong, et al.
Published: (2021-03-01)

Use of computed tomography-derived body composition to determine the prognosis of patients with primary liver cancer treated with immune checkpoint inhibitors: a retrospective cohort study
by: Cui, H., et al.
Published: (2022)

Integrated genomic analysis identifies a genetic mutation model predicting response to immune checkpoint inhibitors in melanoma
by: Junjie Jiang, et al.
Published: (2020-11-01)

Cannot write session to /tmp/vufind_sessions/sess_l5ohs647uvg6qnofl7qt7acjng